Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain

PURPOSE: Data are presented from ophthalmology clinics in Spain participating in the VISIONARY study, examining the effectiveness, tolerability, and safety of the preservative-free tafluprost (0.0015%) and timolol (0.5%) fixed-dose combination (PF tafluprost/timolol FC) in the treatment of OAG and O...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Medina, Jose J., Benitez-del-Castillo, Javier, Rodríguez-Agirretxe, Iñaki, Lopez-Lopez, Fernando, Moreno-Valladares, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048172/
https://www.ncbi.nlm.nih.gov/pubmed/35230148
http://dx.doi.org/10.1089/jop.2021.0099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048172/
https://www.ncbi.nlm.nih.gov/pubmed/35230148
http://dx.doi.org/10.1089/jop.2021.0099

Ejemplares similares